Highest-materiality recent filing
electroCore Q1 revenue $9.6M (+43% YoY); reaffirms ~30% FY2026 growth guidance
Net sales $9.6M, record quarterly revenue, up 43% from $6.7M Q1 2025.
electroCore FY2025 revenue $32M (+27% YoY); CEO Goldberger to retire
Revenue $32.0M, up 27% YoY; US Rx +25%, general wellness +97%.
electroCore prelim FY2025 rev $31.8-32.0M (+26%); Q4 rev ~$9.0-9.2M (+30%)
Preliminary FY2025 revenue $31.8–$32.0M, ~26% growth over FY2024 of $25.2M.
electroCore Q3 net sales $8.7M up 33% YoY; raises FY2025 revenue guidance to $31.5-$32.5M
Net sales $8.7M, 33% increase YoY; YTD net sales $22.8M, up 26% vs first nine months of 2024.
electroCore issues 360,737 shares at $5.145 to settle legal fee obligations
360,737 shares issued at $5.145 per share to settle outstanding legal fees owed to investors.
electroCore appoints Microsoft healthcare head Elena Bonfiglioli to board; declassification fails
Elena Bonfiglioli, Microsoft Global Business Leader Healthcare, appointed to board effective Sept 2, 2025.
electroCore Q2 2025 revenue up 20% to $7.4M; net loss widens to $3.7M; raises $7.2M debt
Net sales $7.4M in Q2 2025, up 20% YoY ($6.1M); YTD sales $14.1M up 22%.
electroCore amends 8-K: NeuroMetrix acquisition deemed not significant; no financials required
Filed 8-K/A on July 16, 2025 to amend the May 2, 2025 original report on the NeuroMetrix merger.
electroCore Q1 revenue up 23% to $6.7M; net loss $3.9M; guides FY25 revenue ~$30M
Q1 2025 revenue $6.7M (+23% YoY); GAAP net loss $3.9M ($0.47 loss per share).
electroCore completes acquisition of NeuroMetrix; $4.49/share plus CVRs
Cash consideration of $4.49 per NURO share; each share also gets one CVR tied to Quell sales milestones.
electroCore replaces auditor Marcum LLP with CBIZ CPAs after attest business acquisition
Marcum LLP resigned as independent registered public accounting firm on April 1, 2025; CBIZ CPAs P.C. engaged for FY 2025.
electroCore FY2024 revenue $25.2M (+57% YoY); net loss narrows to $11.9M
Full year 2024 net sales of $25.2M, up 57% from $16.0M in 2023, driven by 85% growth in VA channel and 174% increase in Truvaga.
Director Charles S. Theofilos resigns from electroCore Board; Board size reduced to seven
Charles S. Theofilos, M.D. resigned as Class III director and from Compensation and Nominating/Governance Committees effective Feb 24, 2025.
electroCore reports preliminary Q4 2024 revenue of $7.07M and FY2024 revenue of $25.2M
Preliminary net revenue for Q4 2024: $7.07 million.
electroCore to acquire NeuroMetrix in cash+CVR merger valuing NURO at net cash plus milestones
NURO shareholders receive pro rata share of net cash (min $8M condition) and one CVR per share.
electroCore enters $20M ATM offering with H.C. Wainwright
ATM agreement allows sale of up to $20M of common stock at market prices.
electroCore Q3 revenue $6.6M, +45% YoY; net loss narrows to $2.5M
Record Q3 revenue of $6.6M, up 45% from $4.5M in Q3 2023; Rx gammaCore VA/DoD sales +75% to $4.8M.
ElectroCore CFO Brian Posner retiring Oct 4, 2024; Joshua Lev appointed CFO
Posner retiring effective Oct 4 for personal/family reasons; will provide consulting services for 12 months.
electroCore Q2 net sales $6.1M (+73% YoY); net loss narrows to $2.7M
Seventh consecutive record quarterly revenue of $6.1M, up 73% YoY from $3.6M.
Director Peter Cuneo reclassified to Class I; to become consultant after 2025 board term
F. Peter Cuneo resigned as Class III director and reappointed as Class I director, term expiring at 2025 Annual Meeting.
electroCore raises $9.3M in equity/warrant offering with $5.645M from insiders
Gross proceeds of ~$9.3M from registered direct & private placements; directors/officers invested $5.645M.
electroCore Q1 net sales up 96% to record $5.4M; GAAP loss narrows to $0.53/share
Record Q1 net sales of $5.4M, up 96% from $2.8M in Q1 2023; driven by VA/DoD (+127%) and Truvaga (+162%).
electroCore reports FY2023 revenue $16.0M, up 87% YoY; Q4 revenue $5.2M, up 103%
Full year 2023 net sales of $16.0M, up 87% from $8.6M; Q4 net sales $5.2M, up 103% from $2.6M.
the Chief Financial Officer of electroCore, Inc. (the "Company"), Brian M. Posner, informed the Board of Directors (the "Board") of the Company that he will be retiring effective as of October 4, 2024 for personal and family reasons.
the Board appointed Joshua S. Lev, as Chief Financial Officer of the Company, effective as of Mr. Posner’s retirement on October 4, 2024.
Max materiality 0.80 · Median 0.65 · Most common event earnings